Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s):  VYYRF

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.


TSXV:VM - Post by User

Comment by BoracayGuyon Jan 10, 2024 1:44pm
133 Views
Post# 35819810

RE:RE:Bids all gone / Going back to .05

RE:RE:Bids all gone / Going back to .05By the end of the year?  There 's products in 30 day stabilization now, with buyers waiting?  This association with RC will likely get VM (full) project financing by year end., IMO.  

There's too much going on to argue with you... Call the company get on the narritive 2024 is VM's year.  Sales commencing ... I wouldn't bail no -  read the last three announcements.  While FDA is stil focus as The US high grade market for barium is totally dependant on one company - we know that - but Health Canada green lights VM to do (sell) internationally. Watch for distrib  deals to kick off sakes, then Canadian pharma to come in .... Not even mentioning the bigger stuff that they are doing with RC.  
<< Previous
Bullboard Posts
Next >>